Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lundbeck
Lundbeck
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
Fierce Biotech
Fri, 11/30/18 - 10:27 am
Lundbeck
Otsuka
brexpiprazole-sertraline
PTSD
clinical trials
Lundbeck’s Lu AF35700 misses schizophrenia endpoint
BioCentury
Thu, 10/25/18 - 11:44 pm
Lundbeck
Lu AF35700
schizophrenia
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
Mon, 08/20/18 - 11:07 pm
FDA
JNJ
Janssen
Lundbeck
Takeda
major depressive disorder
drug development
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck
Fierce Biotech
Mon, 08/20/18 - 10:08 am
Kyowa Hakko Kirin
Parkinson's Disease
KW-6356
Lundbeck
Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post
Xconomy
Mon, 07/2/18 - 10:23 pm
Deborah Dunsire
Lundbeck
Pharma CEOs
Lundbeck Reaches Settlement With US Department of Justice Over Charity Probe
CP Wire
Thu, 06/7/18 - 10:01 am
Lundbeck
settlements
legal
Lundbeck Reaches Settlement With US Department of Justice Over Charity Probe
Thu, 06/7/18 - 10:00 am
Lundbeck
settlements
legal
Lundbeck to pursue M&A again soon
GoinPharma
Sun, 04/29/18 - 12:12 pm
Lundbeck
M&A
Lundbeck bulks up neuro pipeline with Prexton buy
Biopharma Dive
Fri, 03/16/18 - 09:14 pm
Lundbeck
Prexton Therapeutics
M&A
foliglurax
Parkinson's Disease
Gloomy results from the research for an Alzheimer’s therapy
GoinPharma
Thu, 11/30/17 - 09:54 am
Alzheimer's disease
Merck
Eli Lilly
Lundbeck
Biogen
Denali Therapeutics
Yumanity Therapeutics
drug development
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Fierce Pharma
Tue, 09/12/17 - 04:26 pm
Teva Pharmaceutical
executive pay
Pharma CEOs
Lundbeck
Kåre Schultz
Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash
Endpoints
Mon, 09/11/17 - 10:20 am
Teva Pharmaceutical
Lundbeck
Pharma CEOs
Kåre Schultz
23andMe, Lundbeck unveil mega investigation of genetics' role in depression
BioPharma Dive
Thu, 08/3/17 - 10:58 am
23andMe
Lundbeck
genetics
bipolar disorder
major depressive disorder
Tapping into the rare disease market
BioPharma Dive
Fri, 03/10/17 - 09:00 pm
Rare Diseases
Incyte
Horizon Pharma
Lundbeck
Lundbeck reads last rites on another failed PhIII Alzheimer’s program
Endpoints
Wed, 02/8/17 - 09:26 am
Lundbeck
Otsuka
Alzheimer's disease
idalopirdine
Drug maker loses appeal of antitrust pay-to-delay case in Europe
Stat/Pharmalot
Fri, 09/9/16 - 10:23 am
pay-for-delay
Lundbeck
Europe
antidepressants
FDA rejects bid to market antidepressant to treat foggy thinking
Stat
Tue, 03/29/16 - 11:17 am
Takeda
Lundbeck
FDA
antidepressants
Brintellix
Why ViiV Healthcare leads the pharma industry in corporate reputation
BioPharma Dive
Wed, 03/23/16 - 04:23 pm
ViiV Healthcare
Pfizer
GSK
Shionogi
AbbVie
Lundbeck
Janssen
Novo Nordisk
FDA panel backs game-changing cognitive claim for Lundbeck antidepressant Brintellix
Fierce Pharma
Thu, 02/4/16 - 09:17 pm
FDA
antidepressants
Lundbeck
Brintellix
This antidepressant may be no better than cheaper alternatives. But demand could soon soar
Stat
Tue, 02/2/16 - 10:28 am
antidepressants
Lundbeck
Takeda Pharmaceuticals
Brintellix
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »